Followers | 199 |
Posts | 21795 |
Boards Moderated | 2 |
Alias Born | 11/07/2005 |
Thursday, October 12, 2017 10:19:30 AM
Saw this on twitter this morning...any more news on this?
Updated: Oct. 12, 2017
IDVV to Become Medical Marijuana Biotech Firm
(NEW YORK)--International Endeavors Corp. (OTCMKTS:IDVV) on watch as company plans to move deeper into the medical marijuana use by becoming a full scale biotech firm to treat a range of illnesses.
Earlier in the year the Company announced it had broken ground for its boutique winery “CBD Winery” as part of its County Line Village project located at 23446 HWY 79, Warner springs, CA 92086.
The word is the Company is revamping into a biotech stock, and will patent medical grade cannabis strains, that are genetically profiled to treating specific disease, using a unique cryo process.
The end product would be non-psychoactive, meaning the chemical they will be working with will contain no THC, but rather is focused on real biomedical uses only.
The Company is also expected to name a top name individual as new CEO who has deep experience in the cannabis and medical use field. As well as executive changes they may also be bringing on a host of individual scientists with real biotech experience.
The main take away point is that IDVV isn't gonna be your run of the mill cannabis or medical marijuana play, but more in the realm of a 'biotech firm' that conducts its core research on cannabis using a specialized cryo process.
This would place IDVV with similar pure medical marijuana plays such as OWC Pharmaceutical Research Corp (OTC:OWCP) India Globalization Capital, Inc. (NYSE: IGC), or Medical Marijuana Inc. (OTC:MJNA)
News on these developments are expected to be release in the next few days.
http://www.wallstreetnewscast.com/profile/idvv/
Have a great low float, or killer chart to share with our group of traders?
Post it up on my new board!
Sweet Crude's - Low Float and Chart Plays (please join)
http://investorshub.advfn.com/boards/board.aspx?board_id=21852
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM